SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that COVID-19 RT-PCR testing volume has increased in 2022 ...

During the early stages of the coronavirus disease 2019 (COVID-19), rapid testing was imperative for public health policymakers and health care workers in order to determine where and what measures ...

Empower commences COVID-19 RT-PCR testing supported by Kai Medical Laboratory to process daily testing requirements as part of a "Back to Work" and "Back to School" campaign The programs are part of a ...

The accuracy of the RT-PCR test depends on timing; tests are best given within 10 days of COVID-19 symptom development. As the COVID-19 pandemic continues to spread across the country, many nurse ...

BEVERLY, Mass.--(BUSINESS WIRE)--Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today ...

Throughout the COVID-19 pandemic, supply chain shortages of reagents and test kits have limited the rapid expansion of clinical testing needed to contain the virus. Investigators have developed and ...

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...

A microchip technology test kit may facilitate point-of-care testing in remote locations, clinics, and airports while providing similar accuracy to the tube-based real-time PCR tests, investigators ...